View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
August 23, 2022

Europe’s medical devices industry saw a drop of 20.00% in deal activity during July 2022

By Carmen

Europe’s medical devices industry saw a drop of 20% in deal activity during July 2022, when compared with the last 12-month average, led by Peninsula Capital Partners’ $143.03m acquisition of Red Kiwi, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 32 medical devices industry deals worth $318.3m were announced for the region in July 2022, against the 12-month average of 40 deals.

Of all the deal types, venture financing saw most activity in July 2022 with 16 transactions, representing a 50% share for the region.

In second place was M&A with 12 deals, followed by private equity deals with four transactions, respectively capturing a 37.5% and 12.5% share of the overall deal activity for the month.

In terms of value of deals, venture financing was the leading category in Europe’s medical devices industry with $169.93m, while private equity and M&A deals totalled $145.05m and $3.35m, respectively.

Europe medical devices industry deals in July 2022: Top deals

The top five medical devices deals accounted for 88.7% of the overall value during July 2022.

The combined value of the top five medical devices deals stood at $282.4m, against the overall value of $318.3m recorded for the month.

The top five medical devices industry deals of July 2022 tracked by GlobalData were:

1) Peninsula Capital Partners $143.03m private equity deal with Red Kiwi

2) The $100m venture financing of Kerecis ehf by Emerson Collective (Emmerson Collective) and KIRKBI Invest

3) SCR,BNP Paribas Développement SA,Cathay Capital,Credit Mutuel Innovation and Kurma Partners $21.45m venture financing deal with Ganymed Robotics

4) The $10.09m venture financing of PreciPoint by bm-t beteiligungsmanagement thuringen

5) NEST pension fund,Swiss Diabetes Venture Fund,Verve Ventures and Zurcher Kantonalbank $7.83m venture financing deal with Piomic Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network